α-type-1 polarized dendritic cell-based vaccination in recurrent high-grade glioma: a phase I clinical trial

BACKGROUND: High-grade gliomas including glioblastoma multiforme (GBM) are among the most malignant and aggressive of tumors, and have a very poor prognosis despite a temozolomide-based intensive treatment. Therefore, a novel therapeutic approach to controlling recurrence is needed. In the present s...

Descripción completa

Detalles Bibliográficos
Autores principales: Akiyama, Yasuto, Oshita, Chie, Kume, Akiko, Iizuka, Akira, Miyata, Haruo, Komiyama, Masaru, Ashizawa, Tadashi, Yagoto, Mika, Abe, Yoshiaki, Mitsuya, Koichi, Watanabe, Reiko, Sugino, Takashi, Yamaguchi, Ken, Nakasu, Yoko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3541167/
https://www.ncbi.nlm.nih.gov/pubmed/23270484
http://dx.doi.org/10.1186/1471-2407-12-623

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3541167/
https://www.ncbi.nlm.nih.gov/pubmed/23270484
http://dx.doi.org/10.1186/1471-2407-12-623

Ejemplares similares